EICHOR
● Completed
A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC
Condition: Squamous Cell Carcinoma in Situ · Sponsor: Sirnaomics
About this study
The purpose of this trial is to evaluate safety, tolerability and efficacy of various doses of STP705 administered as intralesional injection in subjects with cutaneous squamous cell carcinoma (in situ) skin cancer (isSCC).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (7)
| Investigate MD | Scottsdale, Arizona, United States | — |
| Center for Clinical and Cosmetic Research | Aventura, Florida, United States | — |
| Research Institute of the Southeast LLC | West Palm Beach, Florida, United States | — |
| Dermatology, Laser and Vein Specialists of the Carolinas | Charlotte, North Carolina, United States | — |
| Dermatology Associates of Knoxville | Knoxville, Tennessee, United States | — |
| Tennessee Clinical Research | Nashville, Tennessee, United States | — |
| Austin Institute for Clinical Research | Pflugerville, Texas, United States | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04844983